STYX has been associated with cell proliferation, migration, invasion, and apoptosis in colorectal cancer cells and a range of studies have indicated that STYX acts as a latent oncogene that inhibits apoptosis in colorectal and breast cancer, mainly by binding to FBXW7. This evidence concerns the gene FBXW7 and colorectal cancer.